Company Overview and News

1
What to Watch For in American Express Earnings

4h 247wallst
American Express Co. (NYSE: AXP) is scheduled to release its most recent quarterly results after the markets close on Wednesday. The consensus estimates from Thomson Reuters are $1.82 in earnings per share (EPS) on $10.05 billion in revenue. The second quarter of last year reportedly had EPS of $1.47 and $8.31 billion in revenue.
TRI AXP

1
American Express Must Hold Its 200-Day Simple Moving Average Post-Earnings

2018-07-17 seekingalpha
American Express has made numerous attempts to breakout above my annual pivot of $109.17 since January but has been unable to do so.
AXP

1
American Express Seeks Blockchain Patent

2018-07-16 247wallst
American Express Co. (NYSE: AXP) began testing a blockchain version of its customer rewards program in May and is now going one step deeper into blockchain development with a patent application related to a proof of payment (PoP) system. The idea behind the system is to provide better evidence of payment transactions between merchants and their customers.
AXP

42
Microsoft, Goldman Sachs, IBM and More Dow Stocks to Watch This Week

2018-07-15 247wallst
Earnings reporting season for the second quarter has gotten underway, and 24/7 Wall St. has put together a preview of the Dow Jones industrial average companies scheduled to report their quarterly results this week. Seven of the index’s 30 components are expected to share their results this week. The Dow has been subject to incredible volatility since January, but potentially this earnings season could stabilize the index.
GS.PRB GS.PRA AXP GS GLSSP IBM JBK GEC GE TRV GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI JNJ GS.PRD GS.PRC TRI GNE MSFT GJS GS.PRN UNH GS.PRK

6
Oppenheimer Positive on Banks Into Earnings: 4 to Buy Now

2018-07-13 247wallst
After a sparkling 2017, many of the top bank and financial institution stocks have sputtered in 2018, and with the economy improving and the prospects for interest rates to go higher, the sector may be offering investors some of the best opportunities. Another positive for the industry has been tax reform, which appears to be helping to improve credit quality, which is a huge metric for financial institutions as they are often the lenders of first choice for consumers.
COF.PRG COF.PRH COF-P SLMBP SLMAP COF.WS COF.PRP AXP COF SLM COF-D COF-C COF-F ALLY.PRA ALLY OSM COF.PRC COF.PRD ISM JSM COF.PRF

116
China Blinked - Cramer's Mad Money (7/12/18)

2018-07-13 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, July 12.
APC FB CHDN MA NFLX AXP GOOG VICI SAGE V AMZN JNJ AAPL TSLA KSS PENN AEUA BYD

8
Trump's Looming Trade War - A Rangeley Capital Discussion

2018-07-12 seekingalpha
With the U.S. announcing $200B in tariffs, we appear headed for a trade war. The Rangeley Team discuss what's that means for markets and where we'll likely go from here.
V AXP

272
7 Cryptocurrencies That Outperform Bitcoin

2018-06-30 investorplace
If you have any passing interest in bitcoin, you’ll know that the virtual-currency market has seen better days. The original blockchain-reward token fell worryingly below the $6,000 mark recently, setting fears about additional selloffs. That said, I believe the current juncture offers a shrewd opportunity to consider alternative cryptocurrencies to buy.
BNC BABA EFX AXP MSFT SANT SAN INTC SAN

72
Nike, Exxon Drive the Dow Higher Friday

2018-06-29 247wallst
June 29, 2018: Markets opened higher Friday and held on to early gains as the closing bell draws near. Financial stocks rallied following the Fed’s announcement on stress tests and the banks’ promises to return cash to shareholders, even if one of the banks got a good break. Every sector traded higher in the late afternoon led by energy and materials.
NKE XOM AXP INTC

145
Will Amazon Deal Drive American Express Volume Past Mastercard?

2018-06-26 247wallst
Since losing its exclusive business with Costco back in 2016, American Express Co. (NYSE: AXP) has struggled to regain its spending volume. Between the second and third quarters of 2016, Amex volume dropped by $20 billion and the company fell behind Mastercard Inc. (NYSE: MA) into third place behind volume leader Visa Inc. (NYSE: V).
V AMZN MA AXP

133
3 Big Stock Charts for Tuesday: Bank of America, American Express and Marsh & McLennan | InvestorPlace

2018-06-26 investorplace
Believe it or not, not every stock was trashed on Monday. Campbell Soup (NYSE:CPB) managed a 9% advance on the heels or reports that rival Kraft Heinz (NASDAQ:KHC) was planning to make an acquisition offer.
BAC MMC CPB KHC AXP NFLX NYTAB HOG

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to AXP / American Express Co. on message board site Silicon Investor.

American Express (AXP) AXPW - Axion Power (Bulls Board)
Amalgamated Explorations (AXPL) thread 2 American Express Brokerage -- FREE equity trades
Axcan Pharma Inc. (AXP) Amalgamated Explorations (AXPLE)
Amalgamated Exploration Inc (AXPL) Axcan Pharma; the next biochempharma ??
CUSIP: 025816109